Lymphoma Diffuse

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-08-18
Clinical Trial Update: Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
A Phase 1/2 safety study evaluating different doses of hA20 (Veltuzumab) in CD20+ non-Hodgkin's lymphoma completed.